Te Herenga Waka - Victoria University of Wellington researcher Dr Sarah Sczelecki. Photo: Supplied / Colin McDiarmid
Research into improving the detection of ovarian cancer is set to get a boost thanks to funding from the Cancer Society.
Two Victoria University projects investigating biomarkers of early-stage ovarian cancer are among the studies to get funding as part of the Society's annual national research grant round.
Three post-doctoral fellowships and one PhD scholarship were announced on Thursday as part of the Cancer Society's 2024 National Research Grant Round.
Te Herenga Waka - Victoria University of Wellington researchers Dr Sarah Sczelecki and Sonesavanh Larnkham are conducting research to improve the detection of ovarian cancer.
Te Herenga Waka - Victoria University of Wellington researcher Sonesavanh Larnkham. Photo: Supplied / Cancer Society of New Zealand
Cancer Society research manager Dr Nicole Stanton said the pair's research would build on the exciting results from the Pitman group at Victoria University of Wellington that identified five potential biomarkers of early-stage ovarian cancer.
"They hope to identify the first screening panel of ovarian cancer biomarkers that may be used diagnostically for early detection, enabling prompt treatment, and increased five-year survival rates."
Stanton said ovarian cancer had the highest mortality rate of all gynaecological cancers in Aotearoa, but early diagnosis dramatically improved the survival rates.
"It's actually quite hard to detect at the moment. There isn't a very good test for it to screen for it, and so most people who get diagnosed with ovarian cancer get diagnosed quite late."
Sczelecki and Larnkham's work would involve looking for and putting together tests for biomarkers.
"So that they can screen for ovarian cancer so that it's found earlier and earlier that you can detect it like with most cancers, the better that you can treat it and the more survivable it is."
Post-doctoral fellowships were also awarded to Christchurch-based researchers Dr Citra Praditi and Dr Annika Seddon from the University of Otago.
University of Otago researcher Dr Citra Praditi. Photo: Supplied / Cancer Society of New Zealand
Praditi's research investigates the role of vitamin C (ascorbate) in cancer, in particular, understanding the role it could play as a complementary melanoma therapy.
Seddon is studying malfunctioning mitochondria, to find new and better ways to treat acute myeloid leukaemia.
University of Otago researcher Dr Annika Seddon. Photo: Supplied / Cancer Society of New Zealand
Stanton said there was a huge number of high-quality applications submitted this year.
"I'm particularly excited to see more funding going into ovarian cancer research, which is historically under-studied."
Sign up for Ngā Pitopito Kōrero, a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
